Prescribing trends of SGLT2 inhibitors among HFrEF and HFpEF patients with and without T2DM, 2013–2021
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Prescribing trends of SGLT2 inhibitors among HFrEF and HFpEF patients with and without T2DM, 2013–2021 ; volume:24 ; number:1 ; day:30 ; month:5 ; year:2024 ; pages:1-10 ; date:12.2024
BMC cardiovascular disorders ; 24, Heft 1 (30.5.2024), 1-10, 12.2024
- Urheber
-
Gonzalez, Jimmy
Dave, Chintan V.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12872-024-03961-5
- URN
-
urn:nbn:de:101:1-2408090905394.122763578216
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gonzalez, Jimmy
- Dave, Chintan V.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
Different determinants of exercise capacity in HFpEF compared to HFrEF
From Mouse Models to Patients: A Comparative Bioinformatic Analysis of HFpEF and HFrEF
Inflammation in obesity-related HFpEF: the STEP-HFpEF program
Myocardial phenotypes and dysfunction in HFpEF and HFrEF assessed by echocardiography and cardiac magnetic resonance
Quality of life questionnaire predicts poor exercise capacity only in HFpEF and not in HFrEF
Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort study
Differential impacts of body composition on oxygen kinetics and exercise tolerance of HFrEF and HFpEF patients
Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes
Tolerability and feasibility of beta-blocker titration in HFpEF versus HFrEF: Insights from the CIBIS-ELD trial
Left atrial structure and function in heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF): systematic review and meta-analysis
NASH triggers cardiometabolic HFpEF in aging mice
Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
Different determinants of exercise capacity in HFpEF compared to HFrEF
From Mouse Models to Patients: A Comparative Bioinformatic Analysis of HFpEF and HFrEF
Inflammation in obesity-related HFpEF: the STEP-HFpEF program
Myocardial phenotypes and dysfunction in HFpEF and HFrEF assessed by echocardiography and cardiac magnetic resonance
Quality of life questionnaire predicts poor exercise capacity only in HFpEF and not in HFrEF
Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort study
Differential impacts of body composition on oxygen kinetics and exercise tolerance of HFrEF and HFpEF patients
Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes
Tolerability and feasibility of beta-blocker titration in HFpEF versus HFrEF: Insights from the CIBIS-ELD trial
Left atrial structure and function in heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF): systematic review and meta-analysis
NASH triggers cardiometabolic HFpEF in aging mice
Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
Different determinants of exercise capacity in HFpEF compared to HFrEF
From Mouse Models to Patients: A Comparative Bioinformatic Analysis of HFpEF and HFrEF
Inflammation in obesity-related HFpEF: the STEP-HFpEF program
Myocardial phenotypes and dysfunction in HFpEF and HFrEF assessed by echocardiography and cardiac magnetic resonance
Quality of life questionnaire predicts poor exercise capacity only in HFpEF and not in HFrEF
Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort study
Differential impacts of body composition on oxygen kinetics and exercise tolerance of HFrEF and HFpEF patients
Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes
Tolerability and feasibility of beta-blocker titration in HFpEF versus HFrEF: Insights from the CIBIS-ELD trial
Left atrial structure and function in heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF): systematic review and meta-analysis